A holistic treatment of brain slime

What’s a glioma? Glioma is a relatively common tumor created by central nervous system cells and grows in the brain and spinal cord region. There are gliomas belonging to benigns (Type I and II) and some that have more aggressive characters (Type III and IV). Usually the gliomas that occur at ages over 60 are those with the greatest aggression. The symptoms of the patients vary depending on the anatomical position of the tumour. The most common are persistent headache, a tendency to vomiting, balance and speech disorders as well as seizures. What speciality should I address after the diagnosis of glioma? The gliomas need the expertise partnership. Some gliomas initially need neurosurgeon intervention aimed at the best possible exception, without affecting the quality of life of the patient. If this is not possible, the volume should initially be treated with radiation therapy and then oncologically with chemotherapy or immunotherapy. In general, the decision on the course of treatment must be made by a specialised oncology board in the presence of all relevant specialties. Writes Professor of Neurosurgery, Director of Clinical Minorly Invasive Brain Surgery and Spondyl Column, Is there any development in the surgical treatment of aggressive glioblastomas (Glioblastoma) in the last year? In recent years there have been significant developments that have radically changed the survival expectancy of patients suffering from aggressive brain or spinal glioma. To achieve the best exception to the tumor, the neurosurgeon is guided by modern navigation systems (descriptions) and the use of the 5-ALA drug. The tumor cells employ the drug and phosphorize bright red color under the microscope. This is how the best possible exception to the damage is achieved, without affecting the quality of life of the patient neurologically. What’s the cure for low malignancy glioma? Modern studies have shown that the appropriate treatment for low malignancy glioma is surgical exception. Monitoring is not indicated for the treatment of gliomas. The radical exception of damage has clearly better results regarding patient survival and quality of life. The diffuse expansion of gliomas into nervous tissue even in areas of the brain that control important functions makes radical surgery difficult. Now such gliomas are treated with the use of craniotomy alert. During surgery the patient is awake and involved in tests that control important functions, such as speech and limb movement. This method is particularly effective and allows the best possible exemption of volume. He organizes the 3rd International Conference of Medical Innovation and Innovation AMLI (Athens Medical Leadership and Innovation Conference III), from 22 to 24 November 2024, at the Athens Concert Hall. The AMLI 2024 Conference is expected to function as the “vehicle”, where leading scientists from the hospitals of the Athens Medical Group will present the latest trends in their respective areas of expertise. Learn more: